{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:10:52Z","timestamp":1768587052539,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Context<\/jats:title>\n                <jats:p>Cushing syndrome (CS) is associated with different hematological abnormalities. Nevertheless, conflicting data about erythropoiesis in CS have been reported. Furthermore, it is unclear whether CS sex and subtype-specific alterations in red blood cells (RBC) parameters are present.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate sex and subtype-specific changes in RBC in patients with CS at initial diagnosis and after remission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Design<\/jats:title>\n                <jats:p>Retrospective, monocentric study including 210 patients with CS (women, n\u2009=\u2009162) matched 1:1 for sex and age to patients with pituitary microadenomas or adrenal incidentalomas\u00a0(both hormonally inactive). RBC parameters were evaluated at initial diagnosis and after remission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Women with CS had higher hematocrit (median 42.2 <jats:italic>vs<\/jats:italic> 39.7%), hemoglobin (14.1 <jats:italic>vs<\/jats:italic> 13.4\u00a0g\/dl) and mean corpuscular volume (MCV) (91.2 <jats:italic>vs<\/jats:italic> 87.9\u00a0fl) compared to the controls (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Women with Cushing disease (CD) showed higher hematocrit, RBC and hemoglobin levels than those with ectopic Cushing (ECS) (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005). Men with CS had lower hematocrit (42.9 <jats:italic>vs<\/jats:italic> 44.7%), RBC count (4.8 <jats:italic>vs<\/jats:italic> 5.1n*10<jats:sup>6<\/jats:sup>\/\u00b5l) and hemoglobin (14.2 <jats:italic>vs<\/jats:italic> 15.4\u00a0g\/dl), but higher MCV (90.8 <jats:italic>vs<\/jats:italic> 87.5\u00a0fl) than controls (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In men with CS, no subtype-specific differences were identified. Three months after remission hemoglobin decreased in both sexes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CS is characterized by sexual and subtype-specific differences in RBC parameters. Compared to controls, women with CS showed higher hematocrit\/hemoglobin levels, whereas men had lower hematocrit\/hemoglobin, which further decreased directly after remission. Therefore, anemia should be considered as complication of CS in men. In women, differences in RBC parameters may help to differentiate CD from ECS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-023-02128-x","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:02:19Z","timestamp":1686733339000},"page":"101-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-5575","authenticated-orcid":false,"given":"M.","family":"Detomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tamburello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Chifu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kimpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sbiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"issue":"7","key":"2128_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611\u2013629","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2128_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/EJE-22-0211","volume":"187","author":"M Detomas","year":"2022","unstructured":"Detomas M, Altieri B, Chifu I, Remde H, Zhou X, Landwehr LS, Sbiera S, Kroiss M, Fassnacht M, Deutschbein T (2022) Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism. Eur J Endocrinol 187(3):439\u2013449","journal-title":"Eur J Endocrinol"},{"issue":"22","key":"2128_CR3","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1101\/gad.13.22.2996","volume":"13","author":"A Bauer","year":"1999","unstructured":"Bauer A, Tronche F, Wessely O, Kellendonk C, Reichardt HM, Steinlein P, Schutz G, Beug H (1999) The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 13(22):2996\u20133002","journal-title":"Genes Dev"},{"issue":"24","key":"2128_CR4","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.1182\/blood-2011-07-356006","volume":"118","author":"SM Hattangadi","year":"2011","unstructured":"Hattangadi SM, Wong P, Zhang L, Flygare J, Lodish HF (2011) From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 118(24):6258\u20136268","journal-title":"Blood"},{"key":"2128_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3324\/haematol.2021.280542","volume":"108","author":"L Varricchio","year":"2022","unstructured":"Varricchio L, Geer EB, Martelli F, Mazzarini M, Funnell A, Bieker JJ, Papayannopoulou T, Migliaccio AR (2022) Hypercortisolemic Cushing\u2019s patients possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis. Haematologica 108:1053\u20131067","journal-title":"Haematologica"},{"issue":"7","key":"2128_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1182\/blood.V3.7.769.769","volume":"3","author":"J Baez-Villasenor","year":"1948","unstructured":"Baez-Villasenor J, Rath CE, Finch CA (1948) The blood picture in Addison\u2019s disease. Blood 3(7):769\u2013773","journal-title":"Blood"},{"issue":"3","key":"2128_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1530\/EJE-13-0824","volume":"170","author":"AG Ambrogio","year":"2014","unstructured":"Ambrogio AG, De Martin M, Ascoli P, Cavagnini F, Pecori GF (2014) Gender-dependent changes in haematological parameters in patients with Cushing\u2019s disease before and after remission. Eur J Endocrinol 170(3):393\u2013400","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2128_CR8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/BF03344186","volume":"29","author":"A Gursoy","year":"2006","unstructured":"Gursoy A, Dogruk Unal A, Ayturk S, Karakus S, Nur Izol A, Bascil Tutuncu N, Guvener DN (2006) Polycythemia as the first manifestation of Cushing\u2019s disease. J Endocrinol Invest 29(8):742\u2013744","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2128_CR9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/BF03346446","volume":"31","author":"T Dusek","year":"2008","unstructured":"Dusek T, Kastelan D, Solak M, Basic Kinda S, Aganovic I, Korsic M (2008) Polycythemia as the first manifestation of Cushing\u2019s disease. J Endocrinol Invest 31(10):940","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2128_CR10","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2128_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2128_CR12","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1\u2013G34","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2128_CR13","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1210\/jc.2016-2935","volume":"102","author":"TG Travison","year":"2017","unstructured":"Travison TG, Vesper HW, Orwoll E, Wu F, Kaufman JM, Wang Y, Lapauw B, Fiers T, Matsumoto AM, Bhasin S (2017) Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab 102(4):1161\u20131173","journal-title":"J Clin Endocrinol Metab"},{"key":"2128_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.903545","volume":"13","author":"M Detomas","year":"2022","unstructured":"Detomas M, Altieri B, Deutschbein T, Fassnacht M, Dischinger U (2022) Metyrapone versus osilodrostat in the short-term therapy of endogenous Cushing\u2019s syndrome: results from a single center cohort study. Front Endocrinol (Lausanne) 13:903545","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5277","key":"2128_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/2281204a0","volume":"228","author":"JW Byron","year":"1970","unstructured":"Byron JW (1970) Effect of steroids on the cycling of haemopoietic stem cells. Nature 228(5277):1204","journal-title":"Nature"},{"issue":"3","key":"2128_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/(SICI)1096-8652(199811)59:3<230::AID-AJH8>3.0.CO;2-2","volume":"59","author":"R Fonseca","year":"1998","unstructured":"Fonseca R, Rajkumar SV, White WL, Tefferi A, Hoagland HC (1998) Anemia after orchiectomy. Am J Hematol 59(3):230\u2013233","journal-title":"Am J Hematol"},{"issue":"3","key":"2128_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cen.12299","volume":"80","author":"M Zilio","year":"2014","unstructured":"Zilio M, Barbot M, Ceccato F, Camozzi V, Bilora F, Casonato A, Frigo AC, Albiger N, Daidone V, Mazzai L et al (2014) Diagnosis and complications of Cushing\u2019s disease: gender-related differences. Clin Endocrinol (Oxf) 80(3):403\u2013410","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2128_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/949620","volume":"2015","author":"X Liu","year":"2015","unstructured":"Liu X, Zhu X, Zeng M, Zhuang Y, Zhou Y, Zhang Z, Yang Y, Wang Y, Ye H, Li Y (2015) Gender-specific differences in clinical profile and biochemical parameters in patients with Cushing\u2019s disease: a single center experience. Int J Endocrinol 2015:949620","journal-title":"Int J Endocrinol"},{"issue":"6","key":"2128_CR19","first-page":"3439","volume":"24","author":"C Huan","year":"2014","unstructured":"Huan C, Qu Y, Ren Z (2014) Gender differences in presentation and outcome of patients with Cushing\u2019s disease in Han Chinese. Biomed Mater Eng 24(6):3439\u20133446","journal-title":"Biomed Mater Eng"},{"issue":"7","key":"2128_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","volume":"10","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA, Nekic AB, Debono M, Lardo P, Ceccato F et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 10(7):499\u2013508","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2128_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.exphem.2009.02.005","volume":"37","author":"E Stellacci","year":"2009","unstructured":"Stellacci E, Di Noia A, Di Baldassarre A, Migliaccio G, Battistini A, Migliaccio AR (2009) Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells. Exp Hematol 37(5):559\u2013572","journal-title":"Exp Hematol"},{"issue":"19","key":"2128_CR22","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1182\/blood-2010-02-251090","volume":"116","author":"A Vlachos","year":"2010","unstructured":"Vlachos A, Muir E (2010) How I treat Diamond\u2013Blackfan anemia. Blood 116(19):3715\u20133723","journal-title":"Blood"},{"issue":"3","key":"2128_CR23","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/ijms23031886","volume":"23","author":"Z Maceckova","year":"2022","unstructured":"Maceckova Z, Kubickova A, De Sanctis JB, Hajduch M (2022) Effect of glucocorticosteroids in Diamond\u2013Blackfan anaemia: maybe not as elusive as it seems. Int J Mol Sci 23(3):1886","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2128_CR24","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1182\/blood-2014-07-591610","volume":"124","author":"T Barbui","year":"2014","unstructured":"Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B, Pieri L et al (2014) In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood 124(19):3021\u20133023","journal-title":"Blood"},{"issue":"5","key":"2128_CR25","doi-asserted-by":"publisher","first-page":"e248708","DOI":"10.1136\/bcr-2021-248708","volume":"15","author":"AS Badesha","year":"2022","unstructured":"Badesha AS, Khan T, Abdellatif E (2022) Iliac vein deep vein thrombosis as an atypical presentation of an adrenocortical carcinoma. BMJ Case Rep 15(5):e248708","journal-title":"BMJ Case Rep"},{"issue":"9","key":"2128_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1530\/EC-20-0299","volume":"9","author":"J Durmusoglu","year":"2020","unstructured":"Durmusoglu J, Timmers H, van Houten P, Langenhuijsen JF, Hermus A, van de Ven AC (2020) Venous thromboembolism in patients with adrenocortical carcinoma after surgery. Endocr Connect 9(9):874\u2013881","journal-title":"Endocr Connect"},{"issue":"12","key":"2128_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1055\/a-1672-4653","volume":"53","author":"R Halperin","year":"2021","unstructured":"Halperin R, Ahron-Hananel G, Badarna M, Greidinger D, Uri I, Percik R, Tirosh A (2021) Plasma hemoglobin and red blood cell mass levels as dynamic prognostic markers for progression and survival in pancreatic neuroendocrine tumors. Horm Metab Res 53(12):810\u2013817","journal-title":"Horm Metab Res"},{"issue":"1","key":"2128_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12957-021-02452-7","volume":"19","author":"R Gvirtzman","year":"2021","unstructured":"Gvirtzman R, Livovsky DM, Tahover E, Goldin E, Koslowsky B (2021) Anemia can predict the prognosis of colorectal cancer in the pre-operative stage: a retrospective analysis. World J Surg Oncol 19(1):341","journal-title":"World J Surg Oncol"},{"key":"2128_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.844042","volume":"13","author":"S Vignjevic Petrinovic","year":"2022","unstructured":"Vignjevic Petrinovic S, Jaukovic A, Milosevic M, Bugarski D, Budec M (2022) Targeting stress erythropoiesis pathways in cancer. Front Physiol 13:844042","journal-title":"Front Physiol"},{"issue":"2","key":"2128_CR30","volume":"14","author":"J Cheng","year":"2022","unstructured":"Cheng J, Patel G, Dawood A, Aqeel A (2022) Gastric and duodenal neuroendocrine tumor incidentally found on endoscopy during the evaluation of iron-deficiency anemia. Cureus 14(2):e22208","journal-title":"Cureus"},{"issue":"27","key":"2128_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007441","volume":"96","author":"B Xu","year":"2017","unstructured":"Xu B, Wang Y, Li X, Lin J (2017) Nonfunctional pancreatic neuroendocrine tumor masked as anemia: a case report. Medicine (Baltimore) 96(27):e7441","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2128_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12020-015-0608-8","volume":"50","author":"E Hatipoglu","year":"2015","unstructured":"Hatipoglu E, Caglar AS, Caglar E, Ugurlu S, Tuncer M, Kadioglu P (2015) Peptic ulcer disease in endogenous hypercortisolism: myth or reality? Endocrine 50(2):489\u2013495","journal-title":"Endocrine"},{"issue":"6","key":"2128_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1530\/eje.0.1490543","volume":"149","author":"AG Rockall","year":"2003","unstructured":"Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH (2003) Hepatic steatosis in Cushing\u2019s syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149(6):543\u2013548","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2128_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1067\/mlc.2001.119106","volume":"138","author":"S Maruyama","year":"2001","unstructured":"Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, Inoue M, Sagayama A, Umeki K (2001) Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 138(5):332\u2013337","journal-title":"J Lab Clin Med"},{"issue":"6","key":"2128_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/gerona\/glt154","volume":"69","author":"E Bachman","year":"2014","unstructured":"Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, Connor Westfall J, Bae H, Gordeuk V, Bhasin S (2014) Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point. J Gerontol A Biol Sci Med Sci 69(6):725\u2013735","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2128_CR36","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fendo.2019.00862","volume":"10","author":"A Santos","year":"2019","unstructured":"Santos A, Resmini E, Martinez Momblan MA, Valassi E, Martel L, Webb SM (2019) Quality of life in patients with Cushing\u2019s disease. Front Endocrinol (Lausanne) 10:862","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2128_CR37","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1210\/jcem-45-3-488","volume":"45","author":"JP Luton","year":"1977","unstructured":"Luton JP, Thieblot P, Valcke JC, Mahoudeau JA, Bricaire H (1977) Reversible gonadotropin deficiency in male Cushing\u2019s disease. J Clin Endocrinol Metab 45(3):488\u2013495","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02128-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T19:13:47Z","timestamp":1704827627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02128-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["2128"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02128-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local ethics committee of the University Hospital of W\u00fcrzburg (Approval numbers 88\/11 and 85\/12) and carried out in compliance with the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The patients\/participants provided written informed consent to at least one of two disease-specific clinical registries (European Network for the Study of Adrenal Tumors registry (ENSAT) and\/or Network of Excellence for Neuroendocrine Tumors (NeoExNET) registry).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}